IE45998B1 - Prolonged release pharmaceutical preparations - Google Patents

Prolonged release pharmaceutical preparations

Info

Publication number
IE45998B1
IE45998B1 IE2391/77A IE239177A IE45998B1 IE 45998 B1 IE45998 B1 IE 45998B1 IE 2391/77 A IE2391/77 A IE 2391/77A IE 239177 A IE239177 A IE 239177A IE 45998 B1 IE45998 B1 IE 45998B1
Authority
IE
Ireland
Prior art keywords
resin
drug
coating
particles
complex
Prior art date
Application number
IE2391/77A
Other languages
English (en)
Other versions
IE45998L (en
Original Assignee
Pennwalt Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pennwalt Corp filed Critical Pennwalt Corp
Publication of IE45998L publication Critical patent/IE45998L/xx
Publication of IE45998B1 publication Critical patent/IE45998B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
IE2391/77A 1976-11-26 1977-11-25 Prolonged release pharmaceutical preparations IE45998B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74532576A 1976-11-26 1976-11-26
US80010577A 1977-05-24 1977-05-24

Publications (2)

Publication Number Publication Date
IE45998L IE45998L (en) 1978-05-26
IE45998B1 true IE45998B1 (en) 1983-01-26

Family

ID=27114439

Family Applications (1)

Application Number Title Priority Date Filing Date
IE2391/77A IE45998B1 (en) 1976-11-26 1977-11-25 Prolonged release pharmaceutical preparations

Country Status (21)

Country Link
JP (1) JPS609697B2 (fr)
AR (1) AR218047A1 (fr)
AT (1) AT359197B (fr)
AU (1) AU511080B2 (fr)
BE (1) BE861141A (fr)
CA (1) CA1086226A (fr)
CH (1) CH639560A5 (fr)
DE (1) DE2752728C2 (fr)
DK (1) DK150534C (fr)
FI (1) FI65910C (fr)
FR (1) FR2373288A1 (fr)
GB (1) GB1544761A (fr)
GR (1) GR61724B (fr)
IE (1) IE45998B1 (fr)
IL (1) IL53462A (fr)
LU (1) LU78584A1 (fr)
NL (1) NL182283C (fr)
NO (1) NO147626C (fr)
NZ (1) NZ185772A (fr)
PT (1) PT67323B (fr)
SE (1) SE426781B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2929456A1 (de) 1979-07-20 1981-02-05 Lentia Gmbh Zusammensetzung mit verlaengerter broncholytischer und tokolytischer wirksamkeit, ein verfahren zu deren herstellung und broncholytisch und tokolytisch wirkendes mittel
CA1236023A (fr) * 1984-07-18 1988-05-03 Yegnaswami Raghunathan Preparations pharmaceutiques a liberation controlee
US4692462A (en) * 1985-03-18 1987-09-08 Menley & James Laboratories, Ltd. Compositions and method of controlling transdermal penetration of topical and systemic agents
US5612059A (en) * 1988-08-30 1997-03-18 Pfizer Inc. Use of asymmetric membranes in delivery devices
US5188825A (en) * 1989-12-28 1993-02-23 Iles Martin C Freeze-dried dosage forms and methods for preparing the same
EP0542926B1 (fr) * 1990-08-07 1995-02-15 Pfizer Inc. Emploi de membranes a polymerisation interfaciale dans des dispositifs de liberation
US5436011A (en) * 1993-04-16 1995-07-25 Bristol-Myers Squibb Company Solid pharmaceutical dosage form and a method for reducing abrasion
US20130230587A1 (en) * 2010-11-10 2013-09-05 Rubicon Research Private Limited Sustained release compositions
FR3059903B1 (fr) * 2016-12-08 2019-03-22 Salsarulo Pharma Medicament oral comprenant un laxatif osmotique incorpore dans une matrice a base de matieres grasses vegetales
WO2019074829A1 (fr) 2017-10-09 2019-04-18 Rhodes Pharmaceuticals L.P. Compositions pharmaceutiques à base de résinate, et leurs procédés de fabrication et d'utilisation

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE550150A (fr) * 1955-08-08
GB843118A (en) * 1957-02-13 1960-08-04 Ici Ltd Pharmaceutical compositions containing piperidine derivatives
US3158538A (en) * 1961-02-23 1964-11-24 White Lab Inc Antidiarrheal compositions and method of using
GB982150A (en) * 1961-09-29 1965-02-03 Glaxo Group Ltd Therapeutic resin complexes
US3594470A (en) * 1968-02-19 1971-07-20 Abbott Lab Chewable tablets including coated particles of pseudoephedrine-weak cation exchange resin
GB1218102A (en) * 1968-03-15 1971-01-06 Philips Nv Improvements in medicaments comprising drug/ion-exchange resin compounds
CA927282A (en) * 1968-09-03 1973-05-29 S. Banker Gilbert Entrapment compositions and processes
CA935092A (en) * 1968-09-03 1973-10-09 S. Banker Gilbert Molecular drug entrapment process and compositions
DE2343218C2 (de) * 1973-08-28 1986-08-07 Hoechst Ag, 6230 Frankfurt Furosemid enthaltende Pellets

Also Published As

Publication number Publication date
FR2373288B1 (fr) 1980-06-13
JPS609697B2 (ja) 1985-03-12
NO147626C (no) 1983-05-25
ATA848077A (de) 1980-03-15
GR61724B (en) 1978-12-29
NL182283C (nl) 1988-02-16
IL53462A0 (en) 1978-01-31
CA1086226A (fr) 1980-09-23
DE2752728A1 (de) 1978-06-01
NZ185772A (en) 1978-12-18
AR218047A1 (es) 1980-05-15
DK150534C (da) 1987-10-12
DK523277A (da) 1978-05-27
IE45998L (en) 1978-05-26
JPS5369822A (en) 1978-06-21
SE426781B (sv) 1983-02-14
FI773568A (fi) 1978-05-27
SE7713370L (sv) 1978-05-27
DE2752728C2 (de) 1985-08-01
PT67323B (en) 1979-04-24
AU3098677A (en) 1979-05-31
IL53462A (en) 1980-12-31
AT359197B (de) 1980-10-27
BE861141A (fr) 1978-03-16
GB1544761A (en) 1979-04-25
FI65910C (fi) 1984-08-10
FI65910B (fi) 1984-04-30
NO147626B (no) 1983-02-07
PT67323A (en) 1977-12-01
CH639560A5 (en) 1983-11-30
NL182283B (nl) 1987-09-16
LU78584A1 (fr) 1978-04-20
NL7712996A (nl) 1978-05-30
NO774051L (no) 1978-05-29
AU511080B2 (en) 1980-07-24
FR2373288A1 (fr) 1978-07-07
DK150534B (da) 1987-03-23

Similar Documents

Publication Publication Date Title
US4221778A (en) Prolonged release pharmaceutical preparations
Raghunathan et al. Sustained‐release drug delivery system I: Coated ion‐exchange resin system for phenylpropanolamine and other drugs
Guo et al. Ion-exchange resins as drug delivery carriers
JP2941314B2 (ja) 徐放性薬物‐樹脂複合体
EP0368682B1 (fr) Composition pharmaceutique à base d'une résine d'échange ionique
US4847077A (en) Controlled release pharmaceutical preparations
US6001392A (en) Antitussive drugs delivered by ion exchange resins
DK160601B (da) Farmaceutisk harpiksholdigt, sustained release praeparat med kontrolleret afgivelse af et farmaceutisk acceptabelt syreadditionssalt af dextromethorphan samt fremgangsmaade til fremstilling deraf
KR20080108520A (ko) 약물 - 이온교환 수지 복합체를 함유하는 변형 방출 제제
PT642785E (pt) Sistemas de hidrogel heterodisperso de libertacao sustida
US4859461A (en) Coatable ion exchange resins
CA2019108A1 (fr) Formules pharmaceutiques a liberation soutenue
Schacht Ionic polymers as drug carriers
EP0171528A2 (fr) Préparations pharmaceutiques à effet prolongé
EP0254811B1 (fr) Résines échangeuses d'ions enrobées
IE45998B1 (en) Prolonged release pharmaceutical preparations
EP2329813A1 (fr) Compositions aqueuses à libération prolongée pour des agents électrolytes très solubles dans l'eau
Vijay et al. Ion exchange resins and their applications
PT99912A (pt) Processo para a preparacao de uma composicao farmaceutica oral compreendendo particulas de resina de permuta cationica que contem uma droga de poliamina farmacologicamente activa ligada a referida resina
CA1283497C (fr) Resines echangeuses d'ions traitees au polymere
Borodkin Ion-exchange resin delivery systems
Suhagiya et al. Taste masking by ion exchange resin and its new applications: A review
EP2361611A2 (fr) Système d'administration de médicament à libération prolongée aqueuse pour médicaments électrolytiques fortement solubles dans l'eau
Verma et al. Rifabutin loaded floating gellan gum beads: In vitro and in vivo evaluation
Inal et al. Ion exchange resins and applications in pharmaceutical technology

Legal Events

Date Code Title Description
MK9A Patent expired